- Page 1 and 2:
PROJECT SYNOPSES CANCER RESEARCH PR
- Page 3 and 4:
CANCER RESEARCH PROJECTS FUNDED UND
- Page 5 and 6:
TABLE OF CONTENTS FOREWORD - CANCER
- Page 7 and 8:
Prevention 97 EPIC 98 EUROCADET 100
- Page 9 and 10:
CANCER: COMBATING A COMPLEX DISEASE
- Page 11 and 12:
Biology Cancer is a disease ethat t
- Page 13 and 14:
p53 activators ASPP Partner 5 NFkap
- Page 15 and 16:
Keywords | Angiogenesis | vasculoge
- Page 17 and 18:
Keywords | Tumour-host interactions
- Page 19 and 20:
Keywords | Breast | metastasis | ge
- Page 21 and 22:
Keywords | Identifi cation of novel
- Page 23 and 24:
Keywords | Systems biology | modell
- Page 25 and 26:
Keywords | Oncology | anticancer th
- Page 27 and 28:
• public health research coupled
- Page 29 and 30:
Expected results We will construct
- Page 31 and 32:
Potential applications Our DNA is u
- Page 33 and 34:
Microscopic examination of tissue s
- Page 35 and 36:
Pluripotent embryonic stem cells ar
- Page 37 and 38:
• Decryption of the leukaemia cel
- Page 39 and 40:
• identifi cation of molecular ta
- Page 41 and 42:
A B C LT-HSC CSC The Cancer Stem Ce
- Page 43 and 44:
X-ray diff raction of target drug c
- Page 45 and 46:
using pathway-specifi c reporter ce
- Page 47 and 48:
Keywords | Kinases | pediatric panc
- Page 49 and 50:
Keywords | Lymphangiogenesis | angi
- Page 51 and 52:
Keywords | Breast cancer | metastas
- Page 53 and 54:
Keywords | Mitosis | phosphorylatio
- Page 55 and 56:
Keywords | Therapy | genome | telom
- Page 57 and 58:
Keywords | Multiple myeloma | cance
- Page 59 and 60:
Keywords | p53 tumour suppressor |
- Page 61 and 62:
Development of eff ective anti-canc
- Page 63 and 64:
Coordinator Patrick A. Curmi INSERM
- Page 65 and 66:
Drosophila as a model system for tu
- Page 67 and 68:
Normal cell growth and epithelial l
- Page 69 and 70:
effi ciently with cancer cell proli
- Page 71 and 72:
A high-throughput assay of transcri
- Page 73 and 74:
Coordinator Ewa Sikora Nencki Insti
- Page 75 and 76:
Expected results The SIROCCO consor
- Page 77 and 78:
Keywords | Epigenetics | gene regul
- Page 79 and 80:
Keywords | Hereditary | tricarboxyl
- Page 81 and 82:
Keywords | HSV-1 | hepatocellular c
- Page 83 and 84:
Keywords | Apoptosis | autophagy |
- Page 85 and 86:
Keywords | Tumour | host | signalli
- Page 87 and 88:
Aetiology The uncontrolled cell gro
- Page 89 and 90:
Coordinator Rosalind Eeles Reader i
- Page 91 and 92:
The parallelogram approach in CARCI
- Page 93 and 94:
Keywords | Melanoma | genetics | na
- Page 95 and 96:
Keywords | Virus | bacteria | HPV |
- Page 97 and 98:
Keywords | Breast | prostate | gene
- Page 99 and 100:
Prevention The fact that preventing
- Page 101 and 102:
Coordinator Elio Riboli Imperial Co
- Page 103 and 104:
Coordinator Jan Willem Coebergh Joh
- Page 105:
Coordinator Jose M a Benlloch Conse
- Page 108 and 109:
BAMOD Breath-Gas Analysis for Molec
- Page 110 and 111:
BioCare Molecular Imaging for Biolo
- Page 112 and 113:
These centres of excellence will in
- Page 114 and 115:
Expected results Optimise the benef
- Page 116 and 117:
114 Cell proliferation and apoptosi
- Page 118 and 119:
COBRED Colon and Breast cancer Diag
- Page 120 and 121:
DASIM Diagnostic Applications of Sy
- Page 122 and 123:
Expected results Primarily, the res
- Page 124 and 125:
Coordinator John A. Foekens Dept. o
- Page 126 and 127:
124 Aim Drop-Top has two major obje
- Page 128 and 129:
Coordinator Gorka Ochoa Progenika B
- Page 130 and 131:
Expected results The E.E.T.-Pipelin
- Page 132 and 133:
e developed by eTUMOUR is likely to
- Page 134 and 135:
Coordinator Angel Porgador Ben-Guri
- Page 136 and 137:
• the design of a compact assembl
- Page 138 and 139:
Potential applications We believe t
- Page 140 and 141:
Tumor initiation, progression to ma
- Page 142 and 143:
MolDiag-Paca Novel Molecular Diagno
- Page 144 and 145:
NEMO Nano based capsule-Endoscopy w
- Page 146 and 147:
OVCAD Ovarian Cancer - Diagnosis of
- Page 148 and 149:
P-MARK Validation of recently devel
- Page 150 and 151:
POC4life Multiparametric quantum do
- Page 152 and 153:
PROMET Prostate cancer molecular-or
- Page 154 and 155:
Micrometastasis in the bone marrow.
- Page 156 and 157:
and pharmaco-kinetics studies. This
- Page 158 and 159:
Coordinator Raffaella Giavazzi Isti
- Page 160 and 161:
• Development of tools for diagno
- Page 163 and 164:
Treatment Two major problems when t
- Page 165 and 166:
Coordinator Lluis M. Mir UMR 8121 C
- Page 167 and 168:
Potential applications ANGIOSTOP ha
- Page 169 and 170:
Green-fl uorescence protein- expres
- Page 171 and 172:
Coordinator Robert Hawkins Universi
- Page 173 and 174:
Expected results The BACULOGENES pr
- Page 175 and 176:
descriptors of the molecules to be
- Page 177 and 178:
Keywords | Therapeutic vaccine | im
- Page 179 and 180:
Keywords | Cancer chemotherapy | dr
- Page 181 and 182:
Keywords | Children | cancer | leuk
- Page 183 and 184:
Chimaeric TCR shown in context of n
- Page 185 and 186:
Andrea Splendiani Leaf Bioscience s
- Page 187 and 188:
Coordinator Anne O’Garra The Medi
- Page 189 and 190:
Coordinator Jacques Bartholeyns IDM
- Page 191 and 192:
Structure Driven Drug Design The in
- Page 193 and 194:
• acquire fundamental knowledge a
- Page 195 and 196:
Terry Jones Victoria University of
- Page 197 and 198:
Potential applications The use of t
- Page 199 and 200: groups and management structures. T
- Page 201 and 202: T. Barbui Azienda Ospedaliera-Osped
- Page 203 and 204: Keywords | Mantle cell lymphoma | t
- Page 205 and 206: Keywords | Hypoxia | HIF | pericell
- Page 207 and 208: Keywords | Radiation-induced compli
- Page 209 and 210: Keywords | Gene therapy | adenoviru
- Page 211 and 212: Keywords | Dependence receptors | a
- Page 213 and 214: Keywords | Photodynamic therapy | a
- Page 215 and 216: Keywords | Ovarian cancer | thymidy
- Page 217 and 218: Keywords | Quality assurance | clin
- Page 219 and 220: Keywords | Circadian | clocks | cel
- Page 221 and 222: Keywords | Anticancer therapy | onc
- Page 223 and 224: Coordinator Monika Lusky Transgene
- Page 225 and 226: 6 000 women over a three-year perio
- Page 227 and 228: Keywords | Solid tumours | apoptosi
- Page 229 and 230: Keywords | Lymphoma | leukaemia | v
- Page 231: Coordinator Riccardo Dolcetti Centr
- Page 234 and 235: CCPRB Cancer Control using Populati
- Page 236 and 237: EPCRC The European Palliative Care
- Page 238 and 239: EUROCAN+PLUS Feasibility Study for
- Page 240 and 241: EUSTIR A European strategy for the
- Page 242 and 243: NORMOLIFE Development of new therap
- Page 245 and 246: Scientifi c Model Systems The compl
- Page 247 and 248: Performance of benchmarking exercis
- Page 249: • markers correlating with the im
- Page 253 and 254: ● disease markers 131 ● DNA dam
- Page 255 and 256: ● renal 77 ● replication 219
- Page 257 and 258: Bos, Nico A. 56 Boskovic, Darinka 2
- Page 259 and 260: Geley, Stephan 159 Georgopoulos, Li
- Page 261 and 262: Lingner, Joachim 54 Linial, Michal
- Page 263 and 264: Ragno, Pia 115 Rainford, Martyn 92
- Page 265 and 266: Vernos, Isabelle 22 Veronesi, Umber
- Page 267 and 268: ● Centre Hospitalier Universitair
- Page 269 and 270: ● IFOM - Fondazione Istituto FIRC
- Page 271 and 272: ● National University of Ireland
- Page 273 and 274: ● University of Bari 174 ● Univ
- Page 275 and 276: HOW TO OBTAIN EU PUBLICATIONS Our p
Change language